[277] D. Romo, K. Velmurugan, B.L. Upham, L.D. Dwyer-Nield, A.K. Bauer, Dysregulation of gap junction function and cytokine production in response to non-genotoxic polycyclic aromatic hydrocarbons in an in vitro lung cell model, *Cancers* (Basel) 11 (4) (2019).

[278] C. Dietrich, B. Kaina, The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth, *Carcinogenesis* 31 (8) (2010) 1319–1328.

[279] T. Kung, K.A. Murphy, L.A. White, The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism, *Biochem. Pharmacol.* 77 (4) (2009) 536–546.

[280] S. Shimba, K. Komiyama, I. Moro, M. Tezuka, Overexpression of the aryl hydrocarbon receptor (AhR) accelerates the cell proliferation of A549 cells, *J. Biochem.* 132 (5) (2002) 795–802.

[281] M. Hýzfalová, J. Procházková, S. Strapáčová, L. Svržková, O. Vacek, R. Fedr, et al., A prolonged exposure of human lung carcinoma epithelial cells to benzo[a] pyrene induces p21-dependent epithelial-to-mesenchymal transition (EMT)-like phenotype, *Chemosphere* 263 (2021), 128126.

[282] K. Misaki, T. Takamura-Enya, H. Ogawa, K. Takamori, M. Yanagida, Tumour-promoting activity of polycyclic aromatic hydrocarbons and their oxygenated or nitrated derivatives, *Mutagenesis* 31 (2) (2016) 205–213.

[283] K. Chramostová, J. Vondráček, L. Sindlerová, B. Vojtesek, A. Kozubík, M. Machala, Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells, *Toxicol. Appl. Pharmacol.* 196 (1) (2004) 136–148.

[284] Z. Andryšk, J. Procházková, M. Kabátková, L. Umannová, P. Simečková, J. Kohoutek, et al., Aryl hydrocarbon receptor-mediated disruption of contact inhibition is associated with connexin43 downregulation and inhibition of gap junctional intercellular communication, *Arch. Toxicol.* 87 (3) (2013) 491–503.

[285] J. Procházková, M. Kabátková, V. Bryja, L. Umannová, O. Bernatík, A. Kozubík, et al., The interplay of the aryl hydrocarbon receptor and β-catenin alters both AhR-dependent transcription and Wnt/β-catenin signaling in liver progenitors, *Toxicol. Sci.* 122 (2) (2011) 349–360.

[286] J. Svobodová, J. Procházková, M. Kabátková, M. Krkoska, L. Šmerdová, H. Libálová, et al., 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) disrupts control of cell proliferation and apoptosis in a human model of adult liver progenitors, *Toxicol. Sci.* 172 (2) (2019) 368–384.

[287] K. Brune, J. Frank, A. Schwingshackl, J. Finigan, V.K. Sidhaye, Pulmonary epithelial barrier function: some new players and mechanisms, *Am. J. Physiol. Lung Cell. Mol. Physiol.* 308 (8) (2015) L731–L745.

[288] O.H. Wittekindt, Tight junctions in pulmonary epithelia during lung inflammation, *Pflugers Arch.* 469 (1) (2017) 135–147.

[289] D. Kyuno, A. Takasawa, S. Kikuchi, I. Takemasa, M. Osanai, T. Kojima, Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells, *Biochim. Biophys. Acta Biomemb.* 1863 (3) (2021), 183503.

[290] J. Liu, X. Chen, M. Dou, H. He, M. Ju, S. Ji, et al., Particulate matter disrupts airway epithelial barrier via oxidative stress to promote Pseudomonas aeruginosa infection, *J. Thorac. Dis.* 11 (6) (2019) 2617–2627.

[291] S.S. Kim, C.H. Kim, J.W. Kim, H.C. Kung, T.W. Park, Y.S. Shin, et al., Airborne particulate matter increases MUC5AC expression by downregulating Claudin-1 expression in human airway cells, *BMB Rep.* 50 (10) (2017) 516–521.

[292] T. Smyth, J. Veazey, S. Eliseeva, D. Chalupa, A. Elder, S.N. Georas, Diesel exhaust particle exposure reduces expression of the epithelial tight junction protein Tricellulin, Part. Fibre Toxicol. 17 (1) (2020) 52.

[293] M.R. Zeglinski, C.T. Turner, R. Zeng, C. Schwartz, S. Santacruz, M.A. Pawluk, et al., Soluble wood smoke extract promotes barrier dysfunction in alveolar epithelial cells through a MAPK signaling pathway, *Sci. Rep.* 9 (1) (2019) 10027.

[294] D.H. Ho, W.W. Burggren, Blood-brain barrier function, cell viability, and gene expression of tight junction-associated proteins in the mouse are disrupted by crude oil, benzo[a]pyrene, and the dispersant COREXIT, *Comp. Biochem. Physiol. C: Toxicol. Pharmacol.* 223 (2019) 96–105.

[295] C. Tomkiewicz, L. Herry, L.C. Bui, C. Métayer, M. Bourdeloux, R. Barouki, et al., The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway, *Oncogene* 32 (14) (2013) 1811–1820.

[296] P. Wee, Z. Wang, Epidermal growth factor receptor cell proliferation signaling pathways, *Cancers* (Basel) 9 (5) (2017).

[297] P. Lin, H. Chang, W.T. Tsai, M.H. Wu, Y.S. Liao, J.T. Chen, et al., Overexpression of aryl hydrocarbon receptor in human lung carcinomas, *Toxicol. Pathol.* 31 (1) (2003) 22–30.

[298] R. Gouasmi, C. Ferraro-Peyret, S. Nancey, I. Coste, T. Renno, C. Chaveroux, et al., The kynurenine pathway and cancer: Why keep it simple when you can make it complicated, *Cancers* (Basel) 14 (11) (2022).

[299] Y. Liu, X. Liang, W. Dong, Y. Fang, J. Lv, T. Zhang, *J. Tumor-repopulating cells induce PD-1 expression in CD8(+)* T cells by transferring kynurenine and AhR activation. *Cancer Cell.* 2018;33(3):480-94.e7.

[300] Y. Han, D. Liu, L. Li, PD-1/PD-L1 pathway: current researches in cancer, *Am. J. Cancer Res.* 10 (3) (2020) 727–742.

[301] G.Z. Wang, L. Zhang, X.C. Zhao, S.H. Gao, L.W. Qu, H. Yu, et al., The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy, *Nat. Commun.* 10 (1) (2019) 1125.

[302] T.H. Wang, K.Y. Huang, C.C. Chen, Y.H. Chang, H.Y. Chen, C. Hsueh, et al., PM2.5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathway, *EMBO Mol. Med.* 15 (6) (2023) e17014.

[303] S. Nothdurft, C. Thumser-Henner, F. Breitenbücher, R.A. Okimoto, M. Dorsch, C. A. Opitz, et al., Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis, *Oncogenesis.* 9 (11) (2020) 102.

[304] M.A. Sartor, M. Schnekenburger, J.L. Marlowe, J.F. Reichard, Y. Wang, Y. Fan, et al., Genomewide analysis of aryl hydrocarbon receptor binding targets reveals an

extensive array of gene clusters that control morphogenetic and developmental programs, *Environ. Health Perspect.* 117 (7) (2009) 1139–1146.

[305] G. van Niel, G. D'Angelo, G. Raposo, Shedding light on the cell biology of extracellular vesicles, *Nat. Rev. Mol. Cell Biol.* 19 (4) (2018) 213–228.

[306] F. Urabe, N. Kosaka, K. Ito, T. Kimura, S. Egawa, T. Ochiya, Extracellular vesicles as biomarkers and therapeutic targets for cancer, *Am. J. Physiol. Cell Phys.* 318 (1) (2020) C29–C39.

[307] Z. Al Amir Dache, A. Otandault, R. Tanos, B. Pastor, R. Meddeb, C. Sanchez, et al., Blood contains circulating cell-free respiratory competent mitochondria, *FASEB J.* 34 (3) (2020) 3616–3630.

[308] A. Mohan, S. Agarwal, M. Claus, N.S. Britt, N.K. Dhillon, Extracellular vesicles: novel communicators in lung diseases, *Respir. Res.* 21 (1) (2020) 175.

[309] R.Y. Mahida, S. Matsumoto, M.A. Matthay, Extracellular vesicles in ARDS: New insights into pathogenesis with novel clinical applications, in: *J.~L. Vincent (Ed.), Annual Update in Intensive Care and Emergency Medicine 2020*, Springer International Publishing, Cham, 2020, pp. 53–65.

[310] S. Soni, M.R. Wilson, K.P. O'Dea, M. Yoshida, U. Katbeh, S.J. Woods, et al., Alveolar macrophage-derived microvesicles mediate acute lung injury, *Thorax* 71 (11) (2016) 1020–1029.

[311] H. Lee, D. Zhang, Z. Zhu, C.S. Dela Cruz, Y. Jin, Epithelial cell-derived microvesicles activate macrophages and promote inflammation via microvesicle-containing microRNAs, *Sci. Rep.* 6 (1) (2016) 35250.

[312] Y. Liu, Y. Gu, Y. Han, Q. Zhang, Z. Jiang, X. Zhang, et al., Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils, *Cancer Cell* 30 (2) (2016) 243–256.

[313] D. de Miguel-Perez, A. Russo, O. Arrieta, M. Ak, F. Barron, M. Gunasekaran, et al., Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer, *J. Exp. Clin. Cancer Res.* 41 (1) (2022) 186.

[314] C.K. Carberry, J.E. Rager, The impact of environmental contaminants on extracellular vesicles and their key molecular regulators: A literature and database-driven review, *Environ. Mol. Mutagen.* 64 (1) (2023) 50–66.

[315] C.M. Eckhardt, A.A. Baccarelli, H. Wu, Environmental Exposures and Extracellular Vesicles: Indicators of Systemic Effects and Human Disease, *Current Environmental Health Reports.* 9 (3) (2022) 465–476.

[316] M. Le Goff, D. Lagadic-Gossmann, R. Latour, N. Podechard, N. Grova, F. Gauffre, et al., PAHs increase the production of extracellular vesicles both in vitro in endothelial cells and in vivo in urines from rats, *Environ. Pollut.* 255 (Pt 1) (2019), 113171.

[317] N. van Meteren, D. Lagadic-Gossmann, M. Chevanne, I. Gallais, D. Gobart, A. Burel, et al., Polycyclic aromatic hydrocarbons can trigger hepatocyte release of extracellular vesicles by various mechanisms of action depending on their affinity for the aryl hydrocarbon receptor, *Toxicol. Sci.* 171 (2) (2019) 443–462.

[318] Z. Chen, H. Wu, W. Fan, J. Zhang, Y. Yao, W. Su, et al., Naringenin suppresses BEAS-2B-derived extracellular vesicular cargoes disorder caused by cigarette smoke extract thereby inhibiting M1 macrophage polarization, *Front. Immunol.* 13 (2022).

[319] M. Ghildiyal, P.D. Zamore, Small silencing RNAs: an expanding universe, *Nat. Rev. Genet.* 10 (2) (2009) 94–108.

[320] H. Osada, T. Takahashi, let-7 and miR-17-92: Small-sized major players in lung cancer development, *Cancer Sci.* 102 (1) (2011) 9–17.

[321] P.Y. Lin, S.L. Yu, P.C. Yang, MicroRNA in lung cancer, *Br. J. Cancer* 103 (8) (2010) 1144–1148.

[322] M.S. Kumar, J. Lu, K.L. Mercer, T.R. Golub, T. Jacks, Impaired microRNA processing enhances cellular transformation and tumorigenesis, *Nat. Genet.* 39 (5) (2007) 673–677.

[323] M.A. Iqbal, S. Arora, G. Prakasam, G.A. Calin, M.A. Syed, MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance, *Mol. Aspects Med.* 70 (2019) 3–20.

[324] M. Cheng, B. Wang, M. Yang, J. Ma, Z. Ye, L. Xie, et al., microRNAs expression in relation to particulate matter exposure: A systematic review, *Environ. Pollut.* 260 (2020), 113961.

[325] L. Dai, F. Chen, Y. Zheng, D. Zhang, B. Qian, H. Ji, et al., miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling, *FBL, 24* (8) (2019) 1426–1439.

[326] L.R. Barkley, C. Santocanale, MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells, *Oncogenesis.* 2(7):e57-e (2013).

[327] S.-L. Yu, H.-Y. Chen, G.-C. Chang, C.-Y. Chen, H.-W. Chen, S. Singh, et al., MicroRNA signature predicts survival and relapse in lung cancer, *Cancer Cell* 13 (1) (2008) 48–57.

[328] Y. Fujita, K. Kuwano, T. Ochiya, F. Takeshita, The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research, *Biomed. Res. Int.* 2014 (2014), 486413.

[329] A. Izzotti, R. Balansky, G. Ganchev, M. Iltcheva, M. Longobardi, A. Pulliero, et al., Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice, *Oncotarget* 7 (51) (2016) 84758–84774.

[330] V. Bollati, B. Marinelli, P. Apostoli, M. Bonzini, F. Nordio, M. Hoxha, et al., Exposure to metal-Rch particulate matter modifies the expression of candidate microRNAs in peripheral blood leukocytes, *Environ. Health Perspect.* 118 (6) (2010) 763–768.

[331] I. Ryning, V.M. Arlt, K. Vrbova, J. Neca, P. Rossner Jr., J. Klema, et al., Bulky DNA adducts, microRNA profiles, and lipid biomarkers in Norwegian tunnel finishing workers occupationally exposed to diesel exhaust, *Occup. Environ. Med.* 76 (1) (2019) 10–16.
[332] R.S. Rodosthenous, B.A. Coull, Q. Lu, P.S. Vokonas, J.D. Schwartz, A.A. Baccarelli, Ambient particulate matter and microRNAs in extracellular vesicles: a pilot study of older individuals, Part. Fibre Toxicol. 13 (1) (2016) 13.

[333] A. Banerjee, D. Waters, O.M. Camacho, E. Minet, Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure, Biomarkers 20 (2) (2015) 123-131.

[334] T. Ruiz-Vera, Á.C. Ochoa-Martínez, L.G. Pruneda-Alvarez, S. Zarazúa, I.N. Pérez-Maldonado, Exposure to biomass smoke is associated with an increased expression of circulating miRNA-126 and miRNA-155 in Mexican women: a pilot study, Drug Chem. Toxicol. 42 (3) (2019) 335-342.

[335] M.J. Jardim, R.C. Fry, I. Jaspers, L. Dailey, D. Diaz-Sanchez, Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways, Environ. Health Perspect. 117 (11) (2009) 1745-1751.

[336] Z. Xu, N. Wang, Y. Xu, L. Hua, D. Zhou, M. Zheng, et al., Effects of chronic PM2.5 exposure on pulmonary epithelia: transcriptome analysis of mRNA-exosomal miRNA interactions, Toxicol. Lett. 316 (2019) 49-59.

[337] M. Sima, A. Rossnerova, Z. Simova, P. Rossner Jr., The impact of air pollution exposure on the microRNA machinery and lung cancer development, J Pers Med. 11 (1) (2021).

[338] M. Fabbri, A. Paone, F. Calore, R. Galli, E. Gaudio, R. Santhanam, et al., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response, PNAS 109 (31) (2012) E2110-E2116.

[339] Y. Liu, F. Luo, B. Wang, H. Li, Y. Xu, X. Liu, et al., STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells, Cancer Lett. 370 (1) (2016) 125-135.

[340] F. Pontis, L. Roz, M. Mensah, M. Segale, M. Moro, G. Bertolini, et al., Circulating extracellular vesicles from individuals at high-risk of lung cancer induce tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320, J. Exp. Clin. Cancer Res. 40 (1) (2021) 237.

[341] Y. Li, Y. Wei, J. Guo, Y. Cheng, W. He, J. Interactional role of microRNAs and bHLH-PAS proteins in cancer (Review), Int. J. Oncol. 47 (1) (2015) 25-34.

[342] R. Stading, G. Gastelum, C. Chu, W. Jiang, B. Moorthy, Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer, Semin. Cancer Biol. 76 (2021) 3-16.

[343] S. Rogers, A.R. de Souza, M. Zago, M. Iu, N. Guerrina, A. Gomez, et al., Aryl hydrocarbon receptor (AhR)-dependent regulation of pulmonary miRNA by chronic cigarette smoke exposure, Sci. Rep. 7 (1) (2017) 40539.

[344] E. Hecht, M. Zago, M. Sarill, A. Rico de Souza, A. Gomez, J. Matthews, et al., Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation, Toxicol. Appl. Pharmacol. 280 (3) (2014) 511-525.

[345] S.S. Lee, Y.K. Cheah, The interplay between micromeres and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression, J. Immunol. Res. 2019 (2019) 3046379.

[346] A. Abdullah, M. Maged, M.I. Hairul-Islam, I.A. Osama, H. Maha, A. Manal, et al., Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis, PLoS One 14 (4) (2019) e0215981.

[347] R. Souki, J. Amosse, V. Genêt, M. Le Gall, B. Saintpierre, F. Letourneur, et al., Small RNA-sequencing reveals the involvement of microRNA-132 in benzo[a] pyrene-induced toxicity in primary human blood cells, Environ. Pollut. 328 (2023), 121653.

[348] A. Wanet, A. Tacheny, T. Arnould, P. Renard, miR-212-132 expression and functions: within and beyond the neuronal compartment, Nucleic Acids Res. 40 (11) (2012) 4742-4753.

[349] Y. Wang, Q. Sun, Y. Ye, X. Sun, S. Xie, Y. Zhan, et al., FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis, JCI Insight 7 (10) (2022).

[350] S. Tousif, Y. Wang, J. Jackson, K.P. Hough, J.G. Strenkowski, M. Athar, et al., Indoleamine 2, 3-dioxygenase promotes aryl hydrocarbon receptor-dependent differentiation of regulatory B cells in lung cancer, Front. Immunol. 12 (2021), 747780.

[351] W.H. Neamah, P.B. Busbee, H. Alghetaa, O.A. Abdulla, M. Nagarkatti, P. Nagarkatti, AhR activation leads to alterations in the gut microbiome with consequent effect on induction of myeloid derived suppressor cells in a CXCR2-dependent manner, Int. J. Mol. Sci. 21 (24) (2020).

[352] N.K. Altorki, G.J. Markowitz, D. Gao, J.L. Port, A. Saxena, B. Stiles, et al., The lung microenvironment: an important regulator of tumour growth and metastasis, Nat. Rev. Cancer 19 (1) (2019) 9-31.

[353] C.M. Diaz-Montero, M.L. Salem, M.I. Nishimura, E. Garrett-Mayer, D.J. Cole, A. J. Montero, Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy, Cancer Immunol. Immunother. 58 (1) (2009) 49-59.

[354] C.F. Vogel, W.L. Chang, S. Kado, K. McCulloh, H. Vogel, D. Wu, et al., Transgenic overexpression of aryl hydrocarbon receptor repressor (AhRR) and AhR-mediated induction of CYP1A1, cytokines, and acute toxicity, Environ. Health Perspect. 124 (7) (2016) 1071-1083.

[355] M.C. Takenaka, G. Gabriely, V. Rothhammer, I.D. Mascanfroni, M.A. Wheeler, C.-C. Chao, et al., Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39, Nat. Neurosci. 22 (5) (2019) 729-740.

[356] G. Gabriely, F.J. Quintana, Role of AHR in the control of GBM-associated myeloid cells, Semin. Cancer Biol. 64 (2020) 13-18.

[357] W.H. Neamah, N.P. Singh, H. Alghetaa, O.A. Abdulla, S. Chatterjee, P.B. Busbee, et al., AhR activation leads to massive mobilization of myeloid-derived suppressor

cells with immunosuppressive activity through regulation of CXCR2 and microRNA miR-150-5p and miR-543-3p that target anti-inflammatory genes, J. Immunol. 203 (7) (2019) 1830-1844.

[358] C.F. Vogel, S.R. Goth, B. Dong, I.N. Pessah, F. Matsumura, Aryl hydrocarbon receptor signaling mediates expression of indolealdehyde 2,3-dioxygenase, Biochem. Biophys. Res. Commun. 375 (3) (2008) 331-335.

[359] J. Bankoti, B. Rase, T. Simones, D.M. Shepherd, Functional and phenotypic effects of AhR activation in inflammatory dendritic cells, Toxicol. Appl. Pharmacol. 246 (1-2) (2010) 18-28.

[360] C. Dahlem, S.Y. Kado, Y. He, K. Bein, D. Wu, T. Haarmann-Stemmann, et al., AHR signaling interacting with nutritional factors regulating the expression of markers in vascular inflammation and atherogenesis, Int. J. Mol. Sci. 21 (21) (2020).

[361] T. Haarmann-Stemmann, H. Bothe, J. Abel, Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways, Biochem. Pharmacol. 77 (4) (2009) 508-520.

[362] A. Jain, S. Kaczanowska, E. Davila, IL-1 receptor-associated kinase signaling and its role in inflammation, cancer progression, and therapy resistance, Front. Immunol. 5 (2014) 553.

[363] Y. Krelin, E. Voronov, S. Dotan, M. Elkabets, E. Reich, M. Fogel, et al., Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors, Cancer Res. 67 (3) (2007) 1062-1071.

[364] F.A. Lagunas-Rangel, W. Liu, H.B. Schiöth, Can exposure to environmental pollutants be associated with less effective chemotherapy in cancer patients? Int. J. Environ. Res. Public Health 19 (4) (2022).

[365] V. Salemme, G. Centonze, F. Cavallo, P. Defilippi, L. Conti, The crosstalk between tumor cells and the immune microenvironment in breast cancer: Implications for immunotherapy, Front. Oncol. 11 (2021), 610303.

[366] R.D. Hall, T.M. Le, D.E. Haggstrom, R.D. Gentzler, Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC), Transl Lung Cancer Res. 4 (5) (2015) 515-523.

[367] N. Zhang, The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology, J Cardiovasc Dis Res. 2 (2) (2011) 91-95.

[368] T. Yi, J. Wang, K. Zhu, Y. Tang, S. Huang, X. Shui, et al., Aryl hydrocarbon receptor: a new player of pathogenesis and therapy in cardiovascular diseases, Biomed Res. Int. 2018 (2018) 6058784.

[369] W-J. Lee, K-H. Lin, J-S. Wang, WH-H. Sheu, C.-C. Shen, C.-N. Yang, et al., Aryl hydrocarbon receptor deficiency augments dysregulated microangiogenesis and diabetic retinopathy, Biomedicine & Pharmacotherapy. 2022;155:113725.

[370] Y. Li, C. Zhou, W. Lei, K. Wang, J. Zheng, Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†, Biol. Reprod. 103 (5) (2020) 927-937.

[371] J. Gu, L.S. Chan, C.K. Wong, N.S. Wong, C.K. Wong, K.N. Leung, et al., Effect of benzo[a]pyrene on the production of vascular endothelial growth factor by human eosinophilic leukemia EoL-1 cells, J. Environ. Pathol. Toxicol. Oncol. 30 (3) (2011) 241-249.

[372] C.F. Tsai, T.H. Hsieh, J.N. Lee, C.Y. Hsu, Y.C. Wang, F.J. Lai, et al., Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling, BMC Cancer 14 (2014) 556.

[373] Y. Li, C. Zhou, W. Lei, K. Wang, J. Zheng, Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†, Biol. Reprod. 103 (5) (2020) 927-937.

[374] J. Terashima, C. Tachikawa, K. Kudo, W. Habano, S. Ozawa, An aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2, BMC Mol. Biol. 14 (2013) 27.

[375] A.C. Roman, J.M. Carvajal-Gonzalez, E.M. Rico-Leo, P.M. Fernandez-Salguero, Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-α depletion in the endothelium and transforming growth factor-beta overexpression in the stroma, J. Biol. Chem. 284 (37) (2009) 25135-25148.

[376] S. Ichihara, Y. Yamada, G. Ichihara, T. Nakajima, P. Li, T. Kondo, et al., A role for the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis, Arterioscler. Thromb. Vasc. Biol. 27 (6) (2007) 1297-1304.

[377] E.L. Button, D.C. Bersten, M.L. Whitelaw, HIF has Biff - Crosstalk between HIF1α and the family of bHLH/PAS proteins, Exp. Cell Res. 356 (2) (2017) 141-145.

[378] C.R. Fleming, S.M. Billiard, R.T. Di Giulio, Hypoxia inhibits induction of aryl hydrocarbon receptor activity in topinminow hepatocarcinoma cells in an ARNT-dependent manner, Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 150 (3) (2009) 383-389.

[379] M. Zhang, Y. Hu, F. Yang, J. Zhang, J. Zhang, W. Yu, et al., Interaction between AhR and HIF-1 signaling pathways mediated by ARNT/HIF-1β, BMC Pharmacol. Toxicol. 23 (1) (2022) 26.

[380] Z.D. Li, L.Z. Liu, X. Shi, J. Fang, B.H. Jiang, Benzo[a]pyrene-3,6-dione inhibited VEGF expression through inducing HIF-1alpha degradation, Biochem. Biophys. Res. Commun. 357 (2) (2007) 517-523.

[381] J. Ding, J. Li, J. Chen, H. Chen, W. Ouyang, R. Zhang, et al., Effects of polycyclic aromatic hydrocarbons (PAHs) on vascular endothelial growth factor induction through phosphatidylinositol 3-kinase/AP-1-dependent, HIF-1alpha-independent pathway, J. Biol. Chem. 281 (14) (2006) 9093-9100.

[382] I.F. Zattoni, L.C. Delabio, J.P. Dutra, D.H. Kita, G. Scheiffer, M. Hembecker, et al., Targeting breast cancer resistance protein (BCRP/ABCG2): functional inhibitors and expression modulators, Eur. J. Med. Chem. 237 (2022), 114346.

[383] K.P. Tan, B. Wang, M. Yang, P.C. Boutros, J. Macaulay, H. Xu, et al., Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2), Mol. Pharmacol. 78 (2) (2010) 175-185.

[384] B. Yan, S. Liu, Y. Shi, N. Liu, L. Chen, X. Wang, et al., Activation of AhR with nuclear IKKalpha regulates cancer stem-like properties in the occurrence of radiosensitivity, Cell Death Dis. 9 (5) (2018) 490.
[332] R.S. Rodosthenous, B.A. Coull, Q. Lu, P.S. Vokonas, J.D. Schwartz, A.A. Baccarelli, Ambient particulate matter and microRNAs in extracellular vesicles: a pilot study of older individuals, Part. Fibre Toxicol. 13 (1) (2016) 13.

[333] A. Banerjee, D. Waters, O.M. Camacho, E. Minet, Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure, Biomarkers 20 (2) (2015) 123-131.

[334] T. Ruiz-Vera, Á.C. Ochoa-Martínez, L.G. Pruneda-Alvarez, S. Zarazúa, I.N. Pérez-Maldonado, Exposure to biomass smoke is associated with an increased expression of circulating miRNA-126 and miRNA-155 in Mexican women: a pilot study, Drug Chem. Toxicol. 42 (3) (2019) 335-342.

[335] M.J. Jardim, R.C. Fry, I. Jaspers, L. Dailey, D. Diaz-Sanchez, Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways, Environ. Health Perspect. 117 (11) (2009) 1745-1751.

[336] Z. Xu, N. Wang, Y. Xu, L. Hua, D. Zhou, M. Zheng, et al., Effects of chronic PM2.5 exposure on pulmonary epithelia: transcriptome analysis of mRNA-exosomal miRNA interactions, Toxicol. Lett. 316 (2019) 49-59.

[337] M. Sima, A. Rossnerova, Z. Simova, P. Rossner Jr., The impact of air pollution exposure on the microRNA machinery and lung cancer development, J Pers Med. 11 (1) (2021).

[338] M. Fabbri, A. Paone, F. Calore, R. Galli, E. Gaudio, R. Santhanam, et al., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response, PNAS 109 (31) (2012) E2110-E2116.

[339] Y. Liu, F. Luo, B. Wang, H. Li, Y. Xu, X. Liu, et al., STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells, Cancer Lett. 370 (1) (2016) 125-135.

[340] F. Pontis, L. Roz, M. Mensah, M. Segale, M. Moro, G. Bertolini, et al., Circulating extracellular vesicles from individuals at high-risk of lung cancer induce tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320, J. Exp. Clin. Cancer Res. 40 (1) (2021) 237.

[341] Y. Li, Y. Wei, J. Guo, Y. Cheng, W. He, J. Interactional role of microRNAs and bHLH-PAS proteins in cancer (Review), Int. J. Oncol. 47 (1) (2015) 25-34.

[342] R. Stading, G. Gastelum, C. Chu, W. Jiang, B. Moorthy, Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer, Semin. Cancer Biol. 76 (2021) 3-16.

[343] S. Rogers, A.R. de Souza, M. Zago, M. Iu, N. Guerrina, A. Gomez, et al., Aryl hydrocarbon receptor (AhR)-dependent regulation of pulmonary miRNA by chronic cigarette smoke exposure, Sci. Rep. 7 (1) (2017) 40539.

[344] E. Hecht, M. Zago, M. Sarill, A. Rico de Souza, A. Gomez, J. Matthews, et al., Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation, Toxicol. Appl. Pharmacol. 280 (3) (2014) 511-525.

[345] S.S. Lee, Y.K. Cheah, The interplay between micromeres and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression, J. Immunol. Res. 2019 (2019) 3046379.

[346] A. Abdullah, M. Maged, M.I. Hairul-Islam, I.A. Osama, H. Maha, A. Manal, et al., Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis, PLoS One 14 (4) (2019) e0215981.

[347] R. Souki, J. Amosse, V. Genêt, M. Le Gall, B. Saintpierre, F. Letourneur, et al., Small RNA-sequencing reveals the involvement of microRNA-132 in benzo[a] pyrene-induced toxicity in primary human blood cells, Environ. Pollut. 328 (2023), 121653.

[348] A. Wanet, A. Tacheny, T. Arnould, P. Renard, miR-212-132 expression and functions: within and beyond the neuronal compartment, Nucleic Acids Res. 40 (11) (2012) 4742-4753.

[349] Y. Wang, Q. Sun, Y. Ye, X. Sun, S. Xie, Y. Zhan, et al., FGF-2 signaling in nasopharyngeal carcinoma modulates pericyte-macrophage crosstalk and metastasis, JCI Insight 7 (10) (2022).

[350] S. Tousif, Y. Wang, J. Jackson, K.P. Hough, J.G. Strenkowski, M. Athar, et al., Indoleamine 2, 3-dioxygenase promotes aryl hydrocarbon receptor-dependent differentiation of regulatory B cells in lung cancer, Front. Immunol. 12 (2021), 747780.

[351] W.H. Neamah, P.B. Busbee, H. Alghetaa, O.A. Abdulla, M. Nagarkatti, P. Nagarkatti, AhR activation leads to alterations in the gut microbiome with consequent effect on induction of myeloid derived suppressor cells in a CXCR2-dependent manner, Int. J. Mol. Sci. 21 (24) (2020).

[352] N.K. Altorki, G.J. Markowitz, D. Gao, J.L. Port, A. Saxena, B. Stiles, et al., The lung microenvironment: an important regulator of tumour growth and metastasis, Nat. Rev. Cancer 19 (1) (2019) 9-31.

[353] C.M. Diaz-Montero, M.L. Salem, M.I. Nishimura, E. Garrett-Mayer, D.J. Cole, A. J. Montero, Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy, Cancer Immunol. Immunother. 58 (1) (2009) 49-59.

[354] C.F. Vogel, W.L. Chang, S. Kado, K. McCulloh, H. Vogel, D. Wu, et al., Transgenic overexpression of aryl hydrocarbon receptor repressor (AhRR) and AhR-mediated induction of CYP1A1, cytokines, and acute toxicity, Environ. Health Perspect. 124 (7) (2016) 1071-1083.

[355] M.C. Takenaka, G. Gabriely, V. Rothhammer, I.D. Mascanfroni, M.A. Wheeler, C.-C. Chao, et al., Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39, Nat. Neurosci. 22 (5) (2019) 729-740.

[356] G. Gabriely, F.J. Quintana, Role of AHR in the control of GBM-associated myeloid cells, Semin. Cancer Biol. 64 (2020) 13-18.

[357] W.H. Neamah, N.P. Singh, H. Alghetaa, O.A. Abdulla, S. Chatterjee, P.B. Busbee, et al., AhR activation leads to massive mobilization of myeloid-derived suppressor

cells with immunosuppressive activity through regulation of CXCR2 and microRNA miR-150-5p and miR-543-3p that target anti-inflammatory genes, J. Immunol. 203 (7) (2019) 1830-1844.

[358] C.F. Vogel, S.R. Goth, B. Dong, I.N. Pessah, F. Matsumura, Aryl hydrocarbon receptor signaling mediates expression of indolealdehyde 2,3-dioxygenase, Biochem. Biophys. Res. Commun. 375 (3) (2008) 331-335.

[359] J. Bankoti, B. Rase, T. Simones, D.M. Shepherd, Functional and phenotypic effects of AhR activation in inflammatory dendritic cells, Toxicol. Appl. Pharmacol. 246 (1-2) (2010) 18-28.

[360] C. Dahlem, S.Y. Kado, Y. He, K. Bein, D. Wu, T. Haarmann-Stemmann, et al., AHR signaling interacting with nutritional factors regulating the expression of markers in vascular inflammation and atherogenesis, Int. J. Mol. Sci. 21 (21) (2020).

[361] T. Haarmann-Stemmann, H. Bothe, J. Abel, Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways, Biochem. Pharmacol. 77 (4) (2009) 508-520.

[362] A. Jain, S. Kaczanowska, E. Davila, IL-1 receptor-associated kinase signaling and its role in inflammation, cancer progression, and therapy resistance, Front. Immunol. 5 (2014) 553.

[363] Y. Krelin, E. Voronov, S. Dotan, M. Elkabets, E. Reich, M. Fogel, et al., Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors, Cancer Res. 67 (3) (2007) 1062-1071.

[364] F.A. Lagunas-Rangel, W. Liu, H.B. Schiöth, Can exposure to environmental pollutants be associated with less effective chemotherapy in cancer patients? Int. J. Environ. Res. Public Health 19 (4) (2022).

[365] V. Salemme, G. Centonze, F. Cavallo, P. Defilippi, L. Conti, The crosstalk between tumor cells and the immune microenvironment in breast cancer: Implications for immunotherapy, Front. Oncol. 11 (2021), 610303.

[366] R.D. Hall, T.M. Le, D.E. Haggstrom, R.D. Gentzler, Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC), Transl Lung Cancer Res. 4 (5) (2015) 515-523.

[367] N. Zhang, The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology, J Cardiovasc Dis Res. 2 (2) (2011) 91-95.

[368] T. Yi, J. Wang, K. Zhu, Y. Tang, S. Huang, X. Shui, et al., Aryl hydrocarbon receptor: a new player of pathogenesis and therapy in cardiovascular diseases, Biomed Res. Int. 2018 (2018) 6058784.

[369] W-J. Lee, K-H. Lin, J-S. Wang, WH-H. Sheu, C.-C. Shen, C.-N. Yang, et al., Aryl hydrocarbon receptor deficiency augments dysregulated microangiogenesis and diabetic retinopathy, Biomedicine & Pharmacotherapy. 2022;155:113725.

[370] Y. Li, C. Zhou, W. Lei, K. Wang, J. Zheng, Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†, Biol. Reprod. 103 (5) (2020) 927-937.

[371] J. Gu, L.S. Chan, C.K. Wong, N.S. Wong, C.K. Wong, K.N. Leung, et al., Effect of benzo[a]pyrene on the production of vascular endothelial growth factor by human eosinophilic leukemia EoL-1 cells, J. Environ. Pathol. Toxicol. Oncol. 30 (3) (2011) 241-249.

[372] C.F. Tsai, T.H. Hsieh, J.N. Lee, C.Y. Hsu, Y.C. Wang, F.J. Lai, et al., Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling, BMC Cancer 14 (2014) 556.

[373] Y. Li, C. Zhou, W. Lei, K. Wang, J. Zheng, Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†, Biol. Reprod. 103 (5) (2020) 927-937.

[374] J. Terashima, C. Tachikawa, K. Kudo, W. Habano, S. Ozawa, An aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2, BMC Mol. Biol. 14 (2013) 27.

[375] A.C. Roman, J.M. Carvajal-Gonzalez, E.M. Rico-Leo, P.M. Fernandez-Salguero, Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-α depletion in the endothelium and transforming growth factor-beta overexpression in the stroma, J. Biol. Chem. 284 (37) (2009) 25135-25148.

[376] S. Ichihara, Y. Yamada, G. Ichihara, T. Nakajima, P. Li, T. Kondo, et al., A role for the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis, Arterioscler. Thromb. Vasc. Biol. 27 (6) (2007) 1297-1304.

[377] E.L. Button, D.C. Bersten, M.L. Whitelaw, HIF has Biff - Crosstalk between HIF1α and the family of bHLH/PAS proteins, Exp. Cell Res. 356 (2) (2017) 141-145.

[378] C.R. Fleming, S.M. Billiard, R.T. Di Giulio, Hypoxia inhibits induction of aryl hydrocarbon receptor activity in topinminow hepatocarcinoma cells in an ARNT-dependent manner, Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 150 (3) (2009) 383-389.

[379] M. Zhang, Y. Hu, F. Yang, J. Zhang, J. Zhang, W. Yu, et al., Interaction between AhR and HIF-1 signaling pathways mediated by ARNT/HIF-1β, BMC Pharmacol. Toxicol. 23 (1) (2022) 26.

[380] Z.D. Li, L.Z. Liu, X. Shi, J. Fang, B.H. Jiang, Benzo[a]pyrene-3,6-dione inhibited VEGF expression through inducing HIF-1alpha degradation, Biochem. Biophys. Res. Commun. 357 (2) (2007) 517-523.

[381] J. Ding, J. Li, J. Chen, H. Chen, W. Ouyang, R. Zhang, et al., Effects of polycyclic aromatic hydrocarbons (PAHs) on vascular endothelial growth factor induction through phosphatidylinositol 3-kinase/AP-1-dependent, HIF-1alpha-independent pathway, J. Biol. Chem. 281 (14) (2006) 9093-9100.

[382] I.F. Zattoni, L.C. Delabio, J.P. Dutra, D.H. Kita, G. Scheiffer, M. Hembecker, et al., Targeting breast cancer resistance protein (BCRP/ABCG2): functional inhibitors and expression modulators, Eur. J. Med. Chem. 237 (2022), 114346.

[383] K.P. Tan, B. Wang, M. Yang, P.C. Boutros, J. Macaulay, H. Xu, et al., Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2), Mol. Pharmacol. 78 (2) (2010) 175-185.

[384] B. Yan, S. Liu, Y. Shi, N. Liu, L. Chen, X. Wang, et al., Activation of AhR with nuclear IKKalpha regulates cancer stem-like properties in the occurrence of radiosensitivity, Cell Death Dis. 9 (5) (2018) 490.
[385] S. Zhou, J.D. Schuetz, K.D. Bunting, A.M. Colapietro, J. Sampath, J.J. Morris, et al., The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, Nat. Med. 7 (9) (2001) 1028-1034.

[386] L. Ouyang, B. Yan, Y. Liu, C. Mao, M. Wang, N. Liu, et al., The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor, Signal Transduct. Target. Ther. 5 (1) (2020) 78.

[387] L. Therachiyil, O.J. Hussein, S. Uddin, H.M. Korashy, Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: an update on signaling pathways, Semin. Cancer Biol. 86 (Pt 3) (2022) 1186-1202.

[388] M. Cochard, F. Ledoux, Y. Landkocz, Atmospheric fine particulate matter and epithelial mesenchymal transition in pulmonary cells: state of the art and critical review of the in vitro studies, J. Toxicol. Environ. Health B Crit. Rev. 23 (7) (2020) 293-318.

[389] B. Bakir, A.M. Chiarella, J.R. Pitarresi, A.K. Rustgi, EMT, MET, plasticity, and tumor metastasis, Trends Cell Biol. 30 (10) (2020) 764-776.

[390] J. Yang, P. Antin, G. Berx, C. Blanpain, T. Brabletz, M. Bronner, et al., Guidelines and definitions for research on epithelial-mesenchymal transition, Nat. Rev. Mol. Cell Biol. 21 (6) (2020) 341-352.

[391] A.W. Lambert, R.A. Weinberg, Linking EMT programmes to normal and neoplastic epithelial stem cells, Nat. Rev. Cancer 21 (5) (2021) 325-338.

[392] E. Longhin, L. Capasso, C. Battaglia, M.C. Proverbio, C. Cosentino, I. Cifola, et al., Integrative transcriptomic and protein analysis of human bronchial BEAS-2B exposed to seasonal urban particulate matter, Environ. Pollut. 209 (2016) 87-98.

[393] D. Yang, M. Ma, W. Zhou, B. Yang, C. Xiao, Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells, Chemosphere 184 (2017) 289-298.

[394] D. Li, Y. Yun, R. Gao, Oxygenated polycyclic aromatic hydrocarbons (Oxy-PAHs) facilitate lung cancer metastasis by epigenetically regulating the epithelial-to-mesenchymal transition (EMT), Environ. Pollut. 255 (Pt 2) (2019), 113261.

[395] H. Yue, Y. Yun, R. Gao, G. Li, N. Sang, Winter polycyclic aromatic hydrocarbon-bound particulate matter from peri-urban North China promotes lung cancer cell metastasis, Environ. Sci. Tech. 49 (24) (2015) 14484-14493.

[396] A. Bersaas, Y.J. Arnoldussen, M. Sjøberg, A. Haugen, S. Mollerup, Epithelial-mesenchymal transition and FOXA genes during tobacco smoke carcinogen induced transformation of human bronchial epithelial cells, Toxicol. In Vitro 35 (2016) 55-65.

[397] E. Longhin, M. Camatini, A. Bersaas, P. Mantecca, S. Mollerup, The role of SerpinB2 in human bronchial epithelial cells responses to particulate matter exposure, Arch. Toxicol. 92 (9) (2018) 2923-2933.

[398] D. Brauze, SERPINB2-its regulation and interplay with aryl hydrocarbon receptor, J. Appl. Genet. 62 (1) (2021) 99-105.

[399] M. Machala, J. Slavík, O. Kováč, J. Procházková, K. Pěncíková, M. Pařenicová, et al., Changes in sphingolipid profile of benzo[a]pyrene-transformed human bronchial epithelial cells are reflected in the altered composition of sphingolipids in their exosomes, Int. J. Mol. Sci. 22 (17) (2021).

[400] Y.A. Hannun, L.M. Obeid, Sphingolipids and their metabolism in physiology and disease, Nat. Rev. Mol. Cell Biol. 19 (3) (2018) 175-191.

[401] K. Furukawa, Y. Ohmi, Y. Ohkawa, R.H. Bhuiyan, P. Zhang, O. Tajima, et al., New era of research on cancer-associated glycosphingolipids, Cancer Sci. 110 (5) (2019) 1544-1551.

[402] C. Cumin, Y.L. Huang, A. Everest-Dass, F. Jacob, Deciphering the importance of glycosphingolipids on cellular and molecular mechanisms associated with epithelial-to-mesenchymal transition in cancer, Biomolecules 11 (1) (2021).

[403] J.R. Sharma, H. Agraval, U.C.S. Yadav, Cigarette smoke induces epithelial-to-mesenchymal transition, stemness, and metastasis in lung adenocarcinoma cells via upregulated RUNX-2/galectin-3 pathway, Life Sci. 318 (2023), 121480.
[385] S. Zhou, J.D. Schuetz, K.D. Bunting, A.M. Colapietro, J. Sampath, J.J. Morris, et al., The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, Nat. Med. 7 (9) (2001) 1028-1034.

[386] L. Ouyang, B. Yan, Y. Liu, C. Mao, M. Wang, N. Liu, et al., The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor, Signal Transduct. Target. Ther. 5 (1) (2020) 78.

[387] L. Therachiyil, O.J. Hussein, S. Uddin, H.M. Korashy, Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: an update on signaling pathways, Semin. Cancer Biol. 86 (Pt 3) (2022) 1186-1202.

[388] M. Cochard, F. Ledoux, Y. Landkocz, Atmospheric fine particulate matter and epithelial mesenchymal transition in pulmonary cells: state of the art and critical review of the in vitro studies, J. Toxicol. Environ. Health B Crit. Rev. 23 (7) (2020) 293-318.

[389] B. Bakir, A.M. Chiarella, J.R. Pitarresi, A.K. Rustgi, EMT, MET, plasticity, and tumor metastasis, Trends Cell Biol. 30 (10) (2020) 764-776.

[390] J. Yang, P. Antin, G. Berx, C. Blanpain, T. Brabletz, M. Bronner, et al., Guidelines and definitions for research on epithelial-mesenchymal transition, Nat. Rev. Mol. Cell Biol. 21 (6) (2020) 341-352.

[391] A.W. Lambert, R.A. Weinberg, Linking EMT programmes to normal and neoplastic epithelial stem cells, Nat. Rev. Cancer 21 (5) (2021) 325-338.

[392] E. Longhin, L. Capasso, C. Battaglia, M.C. Proverbio, C. Cosentino, I. Cifola, et al., Integrative transcriptomic and protein analysis of human bronchial BEAS-2B exposed to seasonal urban particulate matter, Environ. Pollut. 209 (2016) 87-98.

[393] D. Yang, M. Ma, W. Zhou, B. Yang, C. Xiao, Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells, Chemosphere 184 (2017) 289-298.

[394] D. Li, Y. Yun, R. Gao, Oxygenated polycyclic aromatic hydrocarbons (Oxy-PAHs) facilitate lung cancer metastasis by epigenetically regulating the epithelial-to-mesenchymal transition (EMT), Environ. Pollut. 255 (Pt 2) (2019), 113261.

[395] H. Yue, Y. Yun, R. Gao, G. Li, N. Sang, Winter polycyclic aromatic hydrocarbon-bound particulate matter from peri-urban North China promotes lung cancer cell metastasis, Environ. Sci. Tech. 49 (24) (2015) 14484-14493.

[396] A. Bersaas, Y.J. Arnoldussen, M. Sjøberg, A. Haugen, S. Mollerup, Epithelial-mesenchymal transition and FOXA genes during tobacco smoke carcinogen induced transformation of human bronchial epithelial cells, Toxicol. In Vitro 35 (2016) 55-65.

[397] E. Longhin, M. Camatini, A. Bersaas, P. Mantecca, S. Mollerup, The role of SerpinB2 in human bronchial epithelial cells responses to particulate matter exposure, Arch. Toxicol. 92 (9) (2018) 2923-2933.

[398] D. Brauze, SERPINB2-its regulation and interplay with aryl hydrocarbon receptor, J. Appl. Genet. 62 (1) (2021) 99-105.

[399] M. Machala, J. Slavík, O. Kováč, J. Procházková, K. Pěncíková, M. Pařenicová, et al., Changes in sphingolipid profile of benzo[a]pyrene-transformed human bronchial epithelial cells are reflected in the altered composition of sphingolipids in their exosomes, Int. J. Mol. Sci. 22 (17) (2021).

[400] Y.A. Hannun, L.M. Obeid, Sphingolipids and their metabolism in physiology and disease, Nat. Rev. Mol. Cell Biol. 19 (3) (2018) 175-191.

[401] K. Furukawa, Y. Ohmi, Y. Ohkawa, R.H. Bhuiyan, P. Zhang, O. Tajima, et al., New era of research on cancer-associated glycosphingolipids, Cancer Sci. 110 (5) (2019) 1544-1551.

[402] C. Cumin, Y.L. Huang, A. Everest-Dass, F. Jacob, Deciphering the importance of glycosphingolipids on cellular and molecular mechanisms associated with epithelial-to-mesenchymal transition in cancer, Biomolecules 11 (1) (2021).

[403] J.R. Sharma, H. Agraval, U.C.S. Yadav, Cigarette smoke induces epithelial-to-mesenchymal transition, stemness, and metastasis in lung adenocarcinoma cells via upregulated RUNX-2/galectin-3 pathway, Life Sci. 318 (2023), 121480.